FDA Advisors Recommend Against Using Codeine for Pain and Cough in Children — Physician’s First Watch

Medical News |
December 11, 2015

FDA Advisors Recommend Against Using Codeine for Pain and Cough in Children

By Kelly Young

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

An advisory committee to the FDA has recommended that codeine be contraindicated for pain and cough management in children and adolescents over concerns of respiratory depression and death. In addition, they recommended restricting codeine's over-the-counter availability for this group.

Of 29 voting members, 20 voted to contraindicate use of the drug for pain and cough in children younger than 18 years old. Most of the others voted to restrict its use only in younger children.

Currently, codeine products have a boxed warning that recommends against their use in children undergoing adenoidectomy or tonsillectomy. In Europe, codeine is contraindicated in children under age 12 for cold and cough, and the European Medicines Agency recommends against using the drug in those aged 12 to 18 years old who have breathing difficulties.

The FDA is not required to follow the recommendations of its advisory committees, but it usually does.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.